Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2012-11-19

Opinion for Abbott Labs (ABT-N)

Signal Price Bias Subject Owned
TOP PICK $62.920 BULLISH NORTH AMERICAN - LARGE Yes

12 drugs under patent after a current one comes off patent.  A hepatitis drug is about to come out as well.  It could hit its 52 week high.

Mohsin Bashir
VP, Stone Asset Management

No Comments.


You must be logged in to comment.